Antimicrobial resistance (AMR) - the resistance of microorganisms including bacteria and viruses to medicines that are used to treat the infections they cause - is a growing concern not only for the healthcare sector but, increasingly, for security and resilience.
In January 2013, the Department of Health will publish its new UK Five Year Antimicrobial Resistance Strategy and Action Plan 2013-2018, which builds on international strategies to combat AMR, including the 2011 EU Strategic Action Plan and 2012 EU Council Conclusions, and the 2011 report by the Transatlantic Task Force on Antimicrobial Resistance, Recommendations for future collaboration between the US and EU.
This workshop, co-hosted by RUSI and the Science and Technology Facilities Council, focused on what further research needs to be funded in order to ensure that the current Strategies and Action Plans can be implemented and followed. It sought to identify gaps in current research knowledge so that future funding calls, by the STFC and other funding bodies, can look to address existing shortfalls, and encouraged knowledge transfer between the security and health sectors.
Reducing use of antibiotics in hospital settings
Detecting and containing infection spread
Information sharing and knowledge transfer to monitor disease outbreak and transmission
Charles Penn, Co-ordinator, Pandemic and Epidemic Diseases, World Health Organization.
Mark Turner, Chair, Guideline Development Group, NICE Clinical Guideline 149 Antibiotics for early-onset neonatal infection.
Gp Captain Andy Green, Director of Infection Prevention & Control Royal, Defence Consultant in Communicable Disease, Centre for Defence Medicine.
Professor Mike Sharland, Chair Advisory Committee on Antimicrobial Resistance and Healthcare, and Paediatric Infectious Diseases Unit, St George's Hospital.